Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.

about

Glucose-6-Phosphate Isomerase (G6PI) Mediates Hypoxia-Induced Angiogenesis in Rheumatoid Arthritis.Hyperthermia enhances the sensitivity of pancreatic cancer SW1990 cells to gemcitabine through ROS/JNK signaling

P2860

Q37571042-AA719682-22D7-4763-B39F-34BC35208CEE Q58572151-AA5C35F4-D7B0-407B-8B09-37EF03114280

P2860

Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.

Item

http://www.wikidata.org/entity/Q39268116

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Hyperthermia reduces migration ...... e motility factor.

@en

Hyperthermia reduces migration ...... e motility factor.

@nl

type

Item

label

Hyperthermia reduces migration ...... e motility factor.

@en

Hyperthermia reduces migration ...... e motility factor.

@nl

prefLabel

Hyperthermia reduces migration ...... e motility factor.

@en

Hyperthermia reduces migration ...... e motility factor.

@nl

P1476

Hyperthermia reduces migration ...... e motility factor.

@en

P2093

Hideomi Watanabe

http://www.w3.org/2001/XMLSchema#string

Kenji Takagishi

http://www.w3.org/2001/XMLSchema#string

Kosei Nakajima

http://www.w3.org/2001/XMLSchema#string

Takashi Yanagawa

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14

Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation.

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program

Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer.

Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.

Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3' sequences.

Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis.

Molecular basis of neurological dysfunction coupled with haemolytic anaemia in human glucose-6-phosphate isomerase (GPI) deficiency.

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials.

P304

1953-1958

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OR.2012.2066

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231742018

http://www.w3.org/2001/XMLSchema#string

P698

23027359

http://www.w3.org/2001/XMLSchema#string

P932

3583516

http://www.w3.org/2001/XMLSchema#string

Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.

about

P2860

P2860

Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932